4-chloro-3-hydroxyanthranilic acid has been researched along with 4-chlorokynurenine in 1 studies
| Studies (4-chloro-3-hydroxyanthranilic acid) | Trials (4-chloro-3-hydroxyanthranilic acid) | Recent Studies (post-2010) (4-chloro-3-hydroxyanthranilic acid) | Studies (4-chlorokynurenine) | Trials (4-chlorokynurenine) | Recent Studies (post-2010) (4-chlorokynurenine) |
|---|---|---|---|---|---|
| 20 | 0 | 2 | 13 | 1 | 6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guidetti, P; Schwarcz, R; Wu, HQ | 1 |
1 other study(ies) available for 4-chloro-3-hydroxyanthranilic acid and 4-chlorokynurenine
| Article | Year |
|---|---|
In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
Topics: 3-Hydroxyanthranilic Acid; Animals; Biotransformation; Corpus Striatum; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Infusions, Parenteral; Kynurenic Acid; Kynurenine; Male; Malonates; Neurons; Neuroprotective Agents; Prodrugs; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Receptors, Glycine | 2000 |